Back to companies
Elicio Therapeutics, Inc.
ELTXUSNASDAQPharmaceuticals & HealthcareElicio Therapeutics, Inc.
Revenue
—
FY2025
Operating income
-$37.7mn
FY2025
Employees
—
Founded
—
Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API